AlphaCrest Capital Management’s Acadia Healthcare ACHC Stock Holding History

AlphaCrest Capital Management’s Portfolio ACHC Stock Details ACHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-2,817	Closed	-$220K	–	15
2022 Q3	$220K	Buy	+2,817	New	+$225K	0.01%	1221
2022 Q2	–	Sell	-8,016	Closed	-$525K	–	1237
2022 Q1	$525K	Sell	8,016 -20,643	-72%	-$1.2M	0.03%	872
2021 Q4	$1.74M	Buy	28,659 +25,140	+714%	+$1.5M	0.06%	500
2021 Q3	$224K	Sell	3,519 -11,389	-76%	-$719K	0.01%	1192
2021 Q2	$935K	Buy	+14,908	New	+$935K	0.04%	696
2021 Q1	–	Sell	-8,989	Closed	-$452K	–	1161
2020 Q4	$452K	Sell	8,989 -5,392	-37%	-$215K	0.04%	708
2020 Q3	$424K	Buy	+14,381	New	+$417K	0.05%	682
2020 Q1	–	Sell	-18,388	Closed	-$611K	–	996
2019 Q4	$611K	Buy	18,388 +8,323	+83%	+$261K	0.05%	655
2019 Q3	$313K	Buy	+10,065	New	+$306K	0.02%	1092

Other funds holding ACHC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AlphaCrest Capital Management's ACHC Position: Q4 2022 in Review

AlphaCrest Capital Management sold out of Acadia Healthcare (ACHC) in Q4 2022, closing a stake of 2,817 shares — an estimated $220K sold.

AlphaCrest Capital Management first reported a position in ACHC in Q3 2019 and held it in 9 quarters. The position peaked at $1.74M in Q4 2021. 346 funds tracked by Wall St. Rank hold ACHC as of Q4 2022.

AlphaCrest Capital Management reported no remaining Acadia Healthcare position as of Q4 2022 after selling out during the quarter.
AlphaCrest Capital Management sold 2,817 Acadia Healthcare shares in Q4 2022, an estimated $220K.
AlphaCrest Capital Management first reported a position in Acadia Healthcare in Q3 2019 and held it in 9 quarters.
AlphaCrest Capital Management's Acadia Healthcare position peaked at $1.74M in Q4 2021.
346 funds tracked by Wall St. Rank held Acadia Healthcare as of Q4 2022.

Based on AlphaCrest Capital Management's 13F filing for Q4 2022.